Oak Thistle LLC Sells 4,179 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Oak Thistle LLC cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 47.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,635 shares of the medical device company's stock after selling 4,179 shares during the period. Oak Thistle LLC's holdings in Cooper Companies were worth $426,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in COO. State Street Corp increased its stake in Cooper Companies by 1.2% in the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after purchasing an additional 104,521 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC increased its position in shares of Cooper Companies by 3.0% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company's stock worth $682,738,000 after acquiring an additional 231,155 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock valued at $527,476,000 after acquiring an additional 48,559 shares during the period. Finally, Victory Capital Management Inc. lifted its position in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock valued at $435,856,000 after acquiring an additional 737,726 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Up 1.3 %

NASDAQ COO traded up $1.23 during trading on Friday, reaching $93.27. The company's stock had a trading volume of 1,950,968 shares, compared to its average volume of 1,451,779. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $18.62 billion, a PE ratio of 47.83, a PEG ratio of 2.29 and a beta of 0.99. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The business has a 50-day moving average price of $96.75 and a 200-day moving average price of $98.85.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the previous year, the business earned $0.87 EPS. Cooper Companies's quarterly revenue was up 9.8% compared to the same quarter last year. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

COO has been the topic of several research analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Citigroup lowered their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Finally, Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.